1. Home
  2. STBA vs STOK Comparison

STBA vs STOK Comparison

Compare STBA & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo S&T Bancorp Inc.

STBA

S&T Bancorp Inc.

HOLD

Current Price

$40.58

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$34.76

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STBA
STOK
Founded
1902
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
2.0B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
STBA
STOK
Price
$40.58
$34.76
Analyst Decision
Hold
Strong Buy
Analyst Count
6
10
Target Price
$43.00
$36.10
AVG Volume (30 Days)
241.2K
589.0K
Earning Date
04-23-2026
04-15-2026
Dividend Yield
3.47%
N/A
EPS Growth
2.35
30.67
EPS
3.49
0.85
Revenue
N/A
$36,555,000.00
Revenue This Year
$10.20
$428.68
Revenue Next Year
$4.14
N/A
P/E Ratio
$11.92
$40.67
Revenue Growth
N/A
316.34
52 Week Low
$30.84
$5.35
52 Week High
$44.91
$39.81

Technical Indicators

Market Signals
Indicator
STBA
STOK
Relative Strength Index (RSI) 37.38 57.06
Support Level $37.06 $30.50
Resistance Level $44.14 $35.75
Average True Range (ATR) 1.37 2.31
MACD -0.41 -0.01
Stochastic Oscillator 15.91 49.89

Price Performance

Historical Comparison
STBA
STOK

About STBA S&T Bancorp Inc.

S&T Bancorp Inc is a bank holding company. The company operates in five markets including Western Pennsylvania, Eastern Pennsylvania, Northeast Ohio, Central Ohio and Upstate New York. The company provides financial services with retail and commercial banking products, cash management services, trust and brokerage services. It operates only in one segment which is Community Banking. The company earns revenue from interest on loans and securities and fees charged for financial services provided to its customers.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: